In conclusion, our study demonstrated that the serum sPD-1 level was significantly reduced in NSCLC patients and that a higher level of serum sPD-1 was found in female patients than in male patients, and the increased testosterone level downregulated the expression of mPD-1 on T cells. Here, HOXD13 is linked to non-small cell lung carcinoma.